Scoring methodology
How Transparent Peptide scores telehealth providers: six weighted categories, published before any ranking is written, with evidence and confidence levels behind every score.
How are the categories weighted?
| Category | Weight | What we assess |
|---|---|---|
| Clinical safety and oversight | 25% | Licensed review, eligibility screening, follow-up, labs, adverse-event process, emergency limits |
| Pharmacy and sourcing transparency | 20% | Named pharmacy, verifiable license, 503A/503B accuracy, disclosed concentration and formulation |
| Total pricing transparency | 20% | Starting, renewal and highest-dose price, all required fees, commitment, cancellation and refund terms |
| Clinician credentials and access | 15% | Named medical lead, verifiable NPI, prescriber access, documented state coverage |
| Patient support and continuity | 10% | Contact channels, response time, refill support, ongoing check-ins |
| Policies and consumer protections | 10% | Visible terms, understandable cancellation, refund rules, privacy, no deceptive urgency |
How confident are we, and on what evidence?
Every score carries a source, a capture date, a reviewer and a confidence level. A provider does not earn full points for an unverifiable claim; we mark facts Verified, Reported, Not disclosed or Contradicted.
Independence and conflicts
Advertising or affiliate relationships never change a score, rank or inclusion. Where we have an ownership conflict (NexLife), the score is signed off by an unaffiliated reviewer and disclosed on the page. See conflicts of interest.
Price normalization
We normalize total cost across covered doses and required fees using one formula, computed for the initial month, ongoing month and 3-, 6- and 12-month totals. See price-verification methodology.
Version history
Methodology v1.0 — released July 12, 2026. Changes to weights or definitions trigger a version increment and re-scoring of all providers, logged in the methodology changelog.